Expert consensus on treatment of Retroperitoneal tumors in china(Edition 2019).
10.3760/cma.j.issn.0253-3766.2019.10.002
- Author:
Chinese Medical Association
;
Cancer Society of Chinese Medical Association
;
Journal of Chinese Medical Association
;
Anorectal Physicians Branch of Chinese Medical Association
;
Professional Committee on Retroperitoneal and Pelvic Floor Diseases, Chinese Research Hospital Association
- Collective Name:Professional Committee on Retroperitoneal and Pelvic Floor Diseases, Chinese Research Hospital Association
- Publication Type:Journal Article
- Keywords:
Expert consensus;
Retroperitoneal neoplasms;
Retroperitoneal sarcoma
- MeSH:
Antineoplastic Agents;
administration & dosage;
adverse effects;
therapeutic use;
China;
Consensus;
Delivery of Health Care;
standards;
Humans;
Practice Guidelines as Topic;
Retroperitoneal Neoplasms;
diagnosis;
drug therapy;
pathology
- From:
Chinese Journal of Oncology
2019;41(10):728-733
- CountryChina
- Language:Chinese
-
Abstract:
The incidence of retroperitoneal tumor is low, and treatment is difficult.According to the recent updates of evidence-based medical evidence at home and abroad, the consensus on the standardized treatment of retroperitoneal tumors were discussed including examination and diagnosis , surgical treatment comprehensive treatment, nutrition, rehabilitation, and review and follow-up, etc.
